ZIMBERELIMAB

UNII:	ZBL7O904IL
Formula:
Preferred Substance Name:	ZIMBERELIMAB
GSRS Full Record:	ZBL7O904IL i

2259860-24-5
AB122
AB-122
ANTI-PD-1 MONOCLONAL ANTIBODY GLS-010
GLS-010
IMMUNOGLOBULIN G4(231-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL AB122 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AB122 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-LAMBDA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (HPD-1, CD279-ANTIGEN)); HOMO SAPIENS MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN HOMO SAPIENS (1-450) (VH (HOMO SAPIENS IGHV4-39*01 (88%) (IGHD)-IGHJ4*01) (10.7.15) (1-123)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(231))) (124-450)) (137-215')-DISULFIDE WITH .LAMBDA. LIGHT CHAIN HOMO SAPIENS (1'-216') (V-LAMBDA (HOMO SAPIENS IGLV2-14*03 (96%) IGLJ3*02)(9.3.10) (1'-110')-HOMO SAPIENS IGLC2*01 (111'-216')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO-K1 CELL LINE, GLYCOFORM ALFA. POST-TRANSLATIONAL MODIFICATIONS: K(450) AND K(450'') DELETED, N(300) AND N(300'') GLYCOSYLATED
WBP3055
WBP-3055
ZIMBERELIMAB [INN]
ZIMBERELIMAB [USAN]
ZIMBERELIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZIMBERELIMAB

Synonyms and Mappings

Resources